Your Next Steps If You Havent Started Retatrutide Yet Have honest conversation with prescribing provider about long-term strategy
AVAILABILITY OF DATA All data not contained either in this manuscript or elsewhere in the published literature (e.g., microsphere quantification, raw pressure-volume loop tracings, raw proteomic values, etc.) but that are germane to the full evaluation of results are fully available upon request made to the corresponding author
Leduc, D., Gallaud, J., Stingl, K
TRIUMPH-4 Used Fixed Dosing: All patients in the 12mg group reached 12mg unless they discontinued
Clinical data shows approximately 25-35% of tirzepatide users experience nausea compared to 20-30% on semaglutide, though most cases resolve within the first month as your body adapts
2018;14(2):148-155.[DOI] 47